Long‐term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1398-9995.2007.01521.xPMID 17686110
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents.

  2007cited by this paper
• Pharmacologic and anti‐IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN)

  2006cited by this paper
• Safety, Tolerability, and Exposure of Ciclesonide Nasal Spray in Healthy and Asymptomatic Subjects With Seasonal Allergic Rhinitis

  2006cited by this paper
• Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium

  2006cited by this paper
• Inflammatory issues in allergic rhinitis and asthma.

  2005cited by this paper
• Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.

  2004cited by this paper
• Effect of intranasal fluticasone propionate and triamcinolone acetonide on basal and dynamic measures of hypothalamic–pituitary–adrenal‐axis activity in healthy volunteers

  2004cited by this paper
• Techniques of Intranasal Steroid Use

  2004cited by this paper
• Intranasal steroid sprays in the treatment of rhinitis: is one better than another?

  2003cited by this paper
• Safety and Tolerability Profiles of Intranasal Antihistamines and Intranasal Corticosteroids in the Treatment of Allergic Rhinitis

  2003cited by this paper
• The Safety of Intranasal Steroids

  2003influential reference
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Consensus statement on the treatment of allergic rhinitis (European Academy of Allergology and Clinical Immunology)

  2001cited by this paper
• Consensus statement * on the treatment of allergic rhinitis

  2000cited by this paper
• Inhaled and nasal corticosteroids: safety aspects*

  2000cited by this paper
• Systemic effects of intranasal steroids: an endocrinologist's perspective.

  2000cited by this paper
• Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology.

  1998cited by this paper
• Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis.

  1998cited by this paper
• Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group.

  1997cited by this paper
• Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.

  1997cited by this paper
• Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients.

  1996cited by this paper
• GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION

  1996cited by this paper
• Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate.

  1993cited by this paper
• Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis.

  1991cited by this paper

• PROFILE OF INTRANASAL CORTICOSTEROIDS IN ITALY: SAFETY, COST/EFFECTIVENESS, LOCAL AND SYSTEMIC ADVERSE EFFECTS.

  2026cites this paper
• Global Ragweed Allergy: Molecular Allergens and Integrated Control Strategies

  2025cites this paper
• Rhinosinusitis.

  2025cites this paper
• Multidimensional assessment of patient-reported outcomes and TCM syndrome improvement in allergic rhinitis: A retrospective cohort study of acupuncture combined with Yu Ping Feng San

  2025cites this paper
• Intranasal antihistamines and corticosteroids in allergic rhinitis: A systematic review and meta-analysis.

  2024cites this paper
• Epistaxis and Clinic Blood Pressure Values: Is There a Relationship?

  2024cites this paper
• Focused allergic rhinitis practice parameter for Canada

  2024cites this paper
• International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

  2023cites this paper
• Comparative efficacy and acceptability of licensed dose intranasal corticosteroids for moderate-to-severe allergic rhinitis: a systematic review and network meta-analysis

  2023cites this paper
• OPTH_A_358066 1675..1695

  2022cites this paper
• Safety of intranasal corticosteroids for allergic rhinitis in children

  2022cites this paper
• Impact of Inhaled and Intranasal Corticosteroids Exposure on the Risk of Ocular Hypertension and Glaucoma: A Systematic Review and Meta-Analysis

  2022cites this paper
• Efficacy and Safety of a Drug-Free, Barrier-Forming Nasal Spray for Allergic Rhinitis: Randomized, Open-Label, Crossover Noninferiority Trial

  2021cites this paper
• Effects of Nigella sativa Extract on Chronic Rhinosinusitis: A Randomized Double Blind Study

  2021cites this paper
• Intranasal Corticosteroid Therapy: Systematic Review and Meta-analysis of Reported Safety and Adverse Effects in Adults

  2020influential citation
• Epistaxis Risk Associated with Intranasal Corticosteroid Sprays: A Systematic Review and Meta-analysis

  2019cites this paper
• Medical Treatment of Pediatric Rhinosinusitis: Focus on Intranasal and Systemic Corticosteroids

  2019cites this paper
• COMMON SITES OF BLEEDING IN EPISTAXIS

  2019cites this paper
• Association between chronic rhinosinusitis and osteoporosis: a case‐control study using a national sample cohort

  2019cites this paper
• Current Approaches to Epistaxis Treatment in Primary and Secondary Care.

  2018cites this paper
• Intranasal Corticosteroids Do Not Lead to Ocular Changes: A Systematic Review and Meta‐analysis

  2018influential citation
• International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

  2018cites this paper
• Treatment of seasonal allergic rhinitis: An evidence-based focused 2017 guideline update.

  2017cites this paper
• Current trends in treatment of allergic rhinitis

  2016cites this paper
• Effects of Fluticasone Furoate on Clinical and Immunological Outcomes (IL-17) for Patients With Nasal Polyposis Naive to Steroid Treatment

  2016cites this paper
• Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis

  2016cites this paper
• Therapeutic Class Overview Intranasal Corticosteroids Therapeutic Class Overview/Summary: Intranasal corticosteroids are primarily used to treat perennial and seasonal allergic rhinitis and may be useful in the treatment of some forms of nonallergic rhinitis.1-14 Symptoms associated with allergic rh

  2016cites this paper
• Pharmacologic Therapies in Pulmonology and Allergy.

  2016cites this paper
• Recent Updates on the Systemic and Local Safety of Intranasal Steroids.

  2016cites this paper
• Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials.

  2015cites this paper
• [Nasally delivered drugs (corticosteroids and vaccines), ultra long-acting bronchodilators and inhaled therapies in an animal model].

  2015cites this paper
• Clinical Practice Guideline

  2015cites this paper
• Long-term efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol.

  2014cites this paper
• Epistaxis: evaluation and treatment.

  2014cites this paper
• Therapeutic Class Overview Attention Deficit/Hyperactivity Disorder (ADHD) Agents and Stimulants

  2014cites this paper
• Preliminary Study of the Safety of Seasonal Allergic Rhinitis Treatment in Railway Personnel

  2014cites this paper
• Long-term, randomized safety study of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) in subjects with chronic rhinitis.

  2014cites this paper
• A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.

  2013cites this paper
• The Effect of Combined Medical Treatment on Quality of Life in Persistent Allergic Rhinitis

  2013cites this paper
• Ocular safety of fluticasone furoate nasal spray in patients with perennial allergic rhinitis: a 2-year study.

  2013cites this paper
• No Mucosal Atrophy and Reduced Inflammatory Cells: Active-controlled Trial with Yearlong Fluticasone Furoate Nasal Spray

  2012cites this paper
• Should Intranasal Corticosteroids Be Used for the Treatment of Ocular Symptoms of Allergic Rhinoconjunctivitis? A Review of Their Efficacy and Safety Profile

  2012cites this paper
• Fluticasone Furoate

  2012cites this paper
• Effect of Intranasal Steroids on Glucose and Hemoglobin A1c Levels in Diabetic Patients

  2012cites this paper
• Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study.

  2012cites this paper
• Что мы знаем о безопасности интраназальных кортикостероидов

  2012cites this paper
• Treatment of Allergic Rhinitis: Anticholinergics, Glucocorticotherapy, Leukotriene Antagonists, Omalizumab and Specific-Allergen Immunotherapy

  2012cites this paper
• Local and systemic safety of intranasal corticosteroids.

  2012cites this paper
• A 26-week Tolerability Study of Ciclesonide Nasal Aerosol in Patients with Perennial Allergic Rhinitis

  2012cites this paper
• Dosing of oral penicillins in children

  2012cites this paper
• Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta‐analysis

  2011cites this paper
• Efficacy and safety of fluticasone furoate nasal spray in Chinese adult and adolescent subjects with intermittent or persistent allergic rhinitis.

  2011cites this paper
• Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review

  2011cites this paper
• Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis.

  2011cites this paper
• Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis.

  2011cites this paper
• Intranasal Steroids in the Treatment of Allergy-Induced Rhinorrhea

  2011cites this paper
• Therapeutic Index (TIX) for intranasal corticosteroids in the treatment of allergic rhinitis.

  2011cites this paper
• Evidence-Based Management of Nasal Polyposis by Intranasal Corticosteroids: From the Cause to the Clinic

  2011cites this paper
• A review of the use of fluticasone furoate since its launch

  2011influential citation
• Is there a role for aerosol nasal sprays in the treatment of allergic rhinitis: a white paper.

  2011cites this paper
• How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA‐GA2LEN statement

  2011cites this paper
• Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis.

  2011cites this paper
• Lack of ocular side effects after 2 years of topical steroids for allergic rhinitis.

  2011cites this paper
• Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated

  2010influential citation
• Fluticasone Furoate Nasal Spray is Effective and Well Tolerated for Perennial Allergic Rhinitis in Adolescents and Adults

  2010cites this paper
• Allergic Rhinitis: Focus on the Intranasal Route of Fluticasone Furoate

  2010cites this paper
• Fluticasone furoate nasal spray: Profile of an enhanced-affinity corticosteroid in treatment of seasonal allergic rhinitis

  2010cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2010 Revision Full Online version - published in the Journal of Allergy and Clinical Immunology

  2010cites this paper
• Medical Management of Nasosinus Infectious and Inflammatory Disease

  2010cites this paper
• Evaluation of Olopatadine Hydrochloride Nasal Spray, 0.6%, Used in Combination with an Intranasal Corticosteroid in Seasonal Allergic Rhinitis

  2010cites this paper
• Comparison of patient preference for sensory attributes of fluticasone furoate or fluticasone propionate in adults with seasonal allergic rhinitis: a randomized, placebo-controlled, double-blind study.

  2010cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

  2010cites this paper
• Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?

  2009cites this paper
• Dissolution in nasal fluid, retention and anti‐inflammatory activity of fluticasone furoate in human nasal tissue ex vivo

  2009cites this paper
• Pediatric allergy medications: review of currently available formulations

  2009cites this paper
• Allergic rhinitis.

  2009cites this paper
• Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis.

  2009cites this paper
• Weather/temperature-sensitive vasomotor rhinitis may be refractory to intranasal corticosteroid treatment.

  2009cites this paper
• Effectiveness of fluticasone furoate 110 μg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen*

  2009cites this paper
• Therapeutic management of allergic diseases

  2009cites this paper
• Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy.

  2009cites this paper
• Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis.

  2009cites this paper
• Pharmacokinetics in special populations

  2009cites this paper
• What has the relief of allergic conjunctivitis by intranasal steroids taught us about the pathophysiology of allergic rhinoconjunctivitis

  2009cites this paper
• Dose-ranging study of fluticasone furoate nasal spray for Japanese patients with perennial allergic rhinitis*

  2008cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

  2008cites this paper
• Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data

  2008cites this paper
• OVERVIEW OF COMMENTS RECEIVED ON DRAFT GUIDELINE ON THE DEVELOPMENT OF PRODUCTS FOR SPECIFC IMMUNOTHERAY FOR THE TREATMENT OF ALLERGIC DISEASE

  2008cites this paper
• Current awareness: Pharmacoepidemiology and drug safety

  2008cites this paper
• Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data.

  2008cites this paper
• Fluticasone furoate nasal spray in the treatment of allergic rhinitis

  2008cites this paper
• Intranasal Mometasone Furoate Alleviates the Ocular Symptoms Associated with Seasonal Allergic Rhinitis: Results of a Post Hoc Analysis

  2008cites this paper
• Intranasal corticosteroids reduce ocular symptoms associated with allergic rhinitis

  2008cites this paper
• Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.

  2008cites this paper
• Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents.

  2008cites this paper
• Drug Class Review: Nasal Corticosteroids

  2008cites this paper
• Fluticasone furoate nasal spray in allergic rhinitis.

  2008cites this paper
• Intranasal corticosteroids: the development of a drug delivery device for fluticasone furoate as a potential step toward improved compliance

  2007cites this paper